Cassie Corneau | executive |
Serge Saxonov | executive |
Justin McAnear | executive |
Mason Carrico | analyst |
Patrick Donnelly | analyst |
Daniel Arias | analyst |
Douglas Schenkel | analyst |
Daniel Brennan | analyst |
Matthew Larew | analyst |
Matthew Sykes | analyst |
Subhalaxmi Nambi | analyst |
Michael Ryskin | analyst |
Tejas Savant | analyst |
Luke Sergott | analyst |
Kyle Mikson | analyst |
Good day, everyone, and welcome to the 10x Genomics First Quarter 2024 Earnings Call. Today's call is being recorded. And I would like to turn the call over to Cassie Corneau, Director, Head of Investor Relations and Strategic Finance. Please go ahead.
Thank you and good afternoon, everyone. Earlier today, 10x Genomics released financial results for the first quarter ended March 31, 2024.